BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 26463141)

  • 21. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
    Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
    J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance reversal in human gastric carcinoma cells by neferine.
    Cao JG; Tang XQ; Shi SH
    World J Gastroenterol; 2004 Oct; 10(20):3062-4. PubMed ID: 15378795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib augments anticancer effects by reversing intrinsic multidrug resistance gene expression in BGC-823 gastric cancer cells.
    Zhu FS; Chen XM; Huang ZG; Wang ZR; Zhang DW; Zhang X
    J Dig Dis; 2010 Feb; 11(1):34-42. PubMed ID: 20132429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
    Xu YD; Shang J; Li M; Zhang YY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2794-2802. PubMed ID: 31002130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
    Kim HB; Kim MJ; Kim DY; Lee JW; Bae JH; Kim DW; Kang CD; Kim SH
    Mol Cancer; 2011 Apr; 10():46. PubMed ID: 21513580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reversing multidrug resistance of epidermoid carcinoma drug-resistant cell line KB-MRP1 by tetrandrine].
    Chen XS; Bao MH; Mei XD
    Ai Zheng; 2007 Aug; 26(8):846-50. PubMed ID: 17697545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RAD001 can reverse drug resistance of SGC7901/DDP cells.
    Ying L; Zu-An Z; Qing-Hua L; Qing-Yan K; Lei L; Tao C; Yong-Ping W
    Tumour Biol; 2014 Sep; 35(9):9171-7. PubMed ID: 24920069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone reverses mitomycin C resistance in human gastric cancer cells.
    Zhang L; Hu JF; Li GQ; Xiao X; Su Q
    Am J Med Sci; 2012 May; 343(5):382-7. PubMed ID: 22052411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing effect of NOTCH1 inhibitor LY3039478 on drug-resistance cells SGC7901/DDP of human gastric cancer and its mechanism.
    Wang YL; Zhang Y; Huang XY; Zheng Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4121-4127. PubMed ID: 30024600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation.
    Yan LH; Wang XT; Yang J; Lian C; Kong FB; Wei WY; Luo W; Xiao Q; Xie YB
    World J Gastroenterol; 2013 Jul; 19(26):4155-65. PubMed ID: 23864778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avicularin reversed multidrug-resistance in human gastric cancer through enhancing Bax and BOK expressions.
    Guo XF; Liu JP; Ma SQ; Zhang P; Sun WD
    Biomed Pharmacother; 2018 Jul; 103():67-74. PubMed ID: 29635130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
    Chen Q; Zhou J; Jiang C; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
    Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
    Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
    Xie C; Pan Y; Hao F; Gao Y; Liu Z; Zhang X; Xie L; Jiang G; Li Q; Wang E
    APMIS; 2014 Dec; 122(12):1251-8. PubMed ID: 25131138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells.
    Song W; Jiang R; Zhao CM
    Asian Pac J Cancer Prev; 2012; 13(11):5619-25. PubMed ID: 23317227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell.
    Zhang YH; Wu Q; Xiao XY; Li DW; Wang XP
    Cancer Lett; 2010 May; 291(1):76-82. PubMed ID: 19883972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
    Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.